• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-3和白细胞介素-6对多发性骨髓瘤患者外周血细胞的影响及其临床意义。

Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance.

作者信息

Goto H, Shimazaki C, Ashihara E, Ohkawa K, Oku N, Inaba T, Murakami S, Fujita N, Nakagawa M

机构信息

Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan.

出版信息

Acta Haematol. 1992;88(2-3):129-35. doi: 10.1159/000204668.

DOI:10.1159/000204668
PMID:1281599
Abstract

The effects of interleukin-3 (IL-3) and interleukin-6 (IL-6) on nonadherent mononuclear cells (NMC) from the peripheral blood of 28 patients with multiple myeloma (MM), 3 patients with monoclonal gammopathy of undetermined significance (MGUS), and 3 normal controls were investigated. In 15 of 27 evaluable patients with MM, monoclonal-cytoplasmic-immunoglobulin (cIg)-positive plasma cells appeared from the T-cell-depleted NMC after 10 days of culture in the presence of IL-3 and IL-6. These changes were not observed in the T cell fraction of myeloma blood or in the T-cell-depleted NMC obtained from cases of MGUS or from normal controls. The percentage of cIg-positive plasmacytoid cells after 10 days of culture was significantly higher in the presence of both IL-3 and IL-6 than with each interleukin alone or the control medium. Furthermore, these changes were often observed in untreated patients. These findings suggest that myeloma precursor cells exist in the peripheral blood of MM patients, especially at diagnosis, and differentiate into cIg-positive cells in the presence of IL-3 and IL-6. This assay may be useful in discriminating the early stage of myeloma from MGUS.

摘要

研究了白细胞介素-3(IL-3)和白细胞介素-6(IL-6)对28例多发性骨髓瘤(MM)患者、3例意义未明的单克隆丙种球蛋白病(MGUS)患者及3名正常对照者外周血中非黏附单核细胞(NMC)的影响。在27例可评估的MM患者中,有15例患者的T细胞去除的NMC在添加IL-3和IL-6的情况下培养10天后出现了单克隆细胞质免疫球蛋白(cIg)阳性浆细胞。在骨髓瘤患者血液的T细胞组分中,以及从MGUS患者或正常对照者获得的T细胞去除的NMC中均未观察到这些变化。培养10天后,同时存在IL-3和IL-6时,cIg阳性浆细胞样细胞的百分比显著高于单独使用每种白细胞介素或对照培养基时。此外,这些变化在未经治疗的患者中也经常观察到。这些发现表明,MM患者外周血中存在骨髓瘤前体细胞,尤其是在诊断时,并且在IL-3和IL-6存在的情况下可分化为cIg阳性细胞。该检测方法可能有助于鉴别骨髓瘤与MGUS的早期阶段。

相似文献

1
Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance.白细胞介素-3和白细胞介素-6对多发性骨髓瘤患者外周血细胞的影响及其临床意义。
Acta Haematol. 1992;88(2-3):129-35. doi: 10.1159/000204668.
2
CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.意义未明单克隆丙种球蛋白病中CD19与骨髓浆细胞免疫表型
J Clin Pathol. 1995 Jun;48(6):548-52. doi: 10.1136/jcp.48.6.548.
3
Tumour necrosis factor-alpha and interleukin 4 promote the differentiation of myeloma cell precursors in multiple myeloma.
Br J Haematol. 1994 Sep;88(1):17-23. doi: 10.1111/j.1365-2141.1994.tb04971.x.
4
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Blood. 1991 Aug 1;78(3):711-9.
5
Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.骨髓瘤患者外周血中循环单克隆B淋巴细胞系细胞上免疫球蛋白轻链mRNA和黏附分子CD11b的表达受限。
Scand J Immunol. 1992 Dec;36(6):843-53. doi: 10.1111/j.1365-3083.1992.tb03146.x.
6
Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro.抗CD40抗体结合可在体外调节人多发性骨髓瘤的克隆形成能力。
Blood. 1994 Nov 1;84(9):3026-33.
7
Tumor necrosis factor-alpha and interleukin 4 in myeloma cell precursor differentiation.肿瘤坏死因子-α与白细胞介素4在骨髓瘤细胞前体分化中的作用
Leuk Lymphoma. 1996 Mar;21(1-2):31-6. doi: 10.3109/10428199609067576.
8
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.多发性骨髓瘤患者外周血中浆细胞和造血祖细胞的同时动员。
J Hematother. 1996 Aug;5(4):339-49. doi: 10.1089/scd.1.1996.5.339.
9
Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.意义未明的单克隆丙种球蛋白病与多发性骨髓瘤之间的发病机制关系。
Stem Cells. 1995 Aug;13 Suppl 2:10-21.
10
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.意义未明的单克隆丙种球蛋白病患者浆细胞的免疫表型特征。对MGUS与多发性骨髓瘤鉴别诊断的意义。
Am J Pathol. 1998 Jun;152(6):1655-65.

引用本文的文献

1
Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.意义未明单克隆丙种球蛋白血症和多发性骨髓瘤的淋巴细胞亚群和炎症细胞因子。
Int J Mol Sci. 2019 Jun 10;20(11):2822. doi: 10.3390/ijms20112822.
2
Biosynthesis of Caffeine in Leaves of Coffee.咖啡叶片中咖啡因的生物合成
Plant Physiol. 1996 Jul;111(3):747-753. doi: 10.1104/pp.111.3.747.
3
Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).
以T细胞相关抗原CD45RO(UCHL-1)免疫组织化学表达为特征的预后不良多发性骨髓瘤的免疫表型和基因分型
J Clin Pathol. 1998 Jun;51(6):432-7. doi: 10.1136/jcp.51.6.432.
4
Expression of adhesion molecules on myeloma cells.骨髓瘤细胞上黏附分子的表达。
Jpn J Cancer Res. 1996 Aug;87(8):837-42. doi: 10.1111/j.1349-7006.1996.tb02108.x.
5
Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro.小鼠抗人白细胞介素-6受体单克隆抗体在体外抑制新鲜人骨髓瘤细胞的增殖。
Jpn J Cancer Res. 1994 Sep;85(9):958-65. doi: 10.1111/j.1349-7006.1994.tb02975.x.